241 related articles for article (PubMed ID: 37110575)
1. Novel Tetrahydro-[1,2,4]triazolo[3,4-
Darwish MIM; Moustafa AM; Youssef AM; Mansour M; Yousef AI; El Omri A; Shawki HH; Mohamed MF; Hassaneen HM; Abdelhamid IA; Oishi H
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110575
[TBL] [Abstract][Full Text] [Related]
2. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and
Alimujiang Y; Maimaiti A; Ablise M; Yang Z; Liu Z; Wang Y; Mutalipu Z; Yan T
Anticancer Agents Med Chem; 2024; 24(6):423-435. PubMed ID: 38204258
[TBL] [Abstract][Full Text] [Related]
5. Chalcone Methoxy Derivatives Exhibit Antiproliferative and Proapoptotic Activity on Canine Lymphoma and Leukemia Cells.
Pawlak A; Henklewska M; Hernández Suárez B; Łużny M; Kozłowska E; Obmińska-Mrukowicz B; Janeczko T
Molecules; 2020 Sep; 25(19):. PubMed ID: 32977440
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of chalcone acetamide derivatives against triple negative breast cancer.
Kumar P; Singh R; Sharma D; Hassan QP; Gopu B; Anal JMH
Bioorg Med Chem Lett; 2024 Jul; 107():129795. PubMed ID: 38750906
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids
Hisham M; Hassan HA; Gomaa HAM; Youssif BGM; Hayalah AM; Abdel-Aziz M
Anticancer Agents Med Chem; 2023; 23(17):1932-1943. PubMed ID: 37497685
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic Effects on Breast Cancer Cell Lines of Chalcones Derived from a Natural Precursor and Their Molecular Docking Analysis.
Bustos L; Echiburú-Chau C; Castro-Alvarez A; Bradshaw B; Simirgiotis MJ; Mellado M; Parra C; Cuellar M
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889260
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.
Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A
Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.
Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):139-144. PubMed ID: 31724435
[TBL] [Abstract][Full Text] [Related]
13. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and antiproliferative activity evaluation of fluorine-containing chalcone derivatives.
Burmaoglu S; Aktas Anil D; Gobek A; Kilic D; Yetkin D; Duran N; Algul O
J Biomol Struct Dyn; 2022 May; 40(8):3525-3550. PubMed ID: 33200677
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of Aspirin-chalcone Mimic Conjugates as Potential Anticancer Agents.
Mohamed-Ezzat RA; Srour AM
Anticancer Agents Med Chem; 2024; 24(7):544-557. PubMed ID: 38204260
[TBL] [Abstract][Full Text] [Related]
16. Chalcones: Potential Chemotherapeutic Compounds and Educational Tools for Closing the Loop in STEM.
Russell AE; Gines BR
Acc Chem Res; 2023 Jun; 56(11):1256-1262. PubMed ID: 36696370
[TBL] [Abstract][Full Text] [Related]
17. Anti-breast cancer activity of heteroaryl chalcone derivatives.
Solomon VR; Lee H
Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
[TBL] [Abstract][Full Text] [Related]
18. Novel [l,2,4]triazolo[3,4-a]isoquinoline chalcones as new chemotherapeutic agents: Block IAP tyrosine kinase domain and induce both intrinsic and extrinsic pathways of apoptosis.
Mohamed MF; Sroor FM; Ibrahim NS; Salem GS; El-Sayed HH; Mahmoud MM; Wagdy MM; Ahmed AM; Mahmoud AT; Ibrahim SS; Ismail MM; Eldin SM; Saleh FM; Hassaneen HM; Abdelhamid IA
Invest New Drugs; 2021 Feb; 39(1):98-110. PubMed ID: 32856275
[TBL] [Abstract][Full Text] [Related]
19. Design and Synthesis of Novel Chalcone Derivatives: Anti-Breast Cancer Activity Evaluation and Docking Study.
Lai W; Chen J; Gao X; Jin X; Chen G; Ye L
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958533
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of chalcone analogues containing a 4-oxoquinazolin-2-yl group as potential anti-tumor agents.
Han X; Peng B; Xiao BB; Sheng-Li Cao ; Yang CR; Wang WZ; Wang FC; Li HY; Yuan XL; Shi R; Liao J; Wang H; Li J; Xu X
Eur J Med Chem; 2019 Jan; 162():586-601. PubMed ID: 30472605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]